Differential regulation of CXCR2 ligands and stem cell-like and mesenchymal phenotypes depends on chemotherapy used.
Drug-resistant cell lines formed smaller primary tumors but were highly metastatic.
Targeting CXCR2 signaling may help circumvent therapy resistance in breast cancer.